Karyopharm Therapeutics Inc.

KPTI Stock Healthcare Biotechnology
$1.85
-0.21 (-10.19%)
Price as of Sep 01, 2026 market close

Performance

1 Month
-6.1%
3 Months
-80.0%
YTD
-74.9%
1 Year
-74.0%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
113.6%
Largest decline max drawdown, since Aug 2025
-83.0%
Risk-adjusted return Sharpe ratio, 1-year
-0.35

Own KPTI?

See how KPTI contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.